Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05649826 · ClinicalTrials.gov registry record
Automated Ultrasound Cardiac Guidance Tool
A clinical trial of Ultrasound Imaging, sponsored by UltraSight.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT05649826: Recruiting study of Ultrasound Imaging, sponsored by UltraSight.
NCT05649826 is a study of Ultrasound Imaging that is actively recruiting participants, run by UltraSight. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05649826, a study of Ultrasound Imaging, is actively recruiting participants, sponsored by UltraSight.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This research examines echocardiography images taken from cardiac patients in relation to the guidance tool developed
Primary Outcome
Several echocardiography views will be acquired from the participants, with in several acoustic windows and views
Conditions Studied
Study Locations (1)
Michigan
- Wayne University - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2027-05-01 |
What NCT05649826 shows while recruiting
NCT05649826 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Ultrasound Imaging appearing as the primary indexed condition, and to 0 interventions.
NCT05649826 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05649826 about?
NCT05649826 is a clinical study titled "Automated Ultrasound Cardiac Guidance Tool". This research examines echocardiography images taken from cardiac patients in relation to the guidance tool developed
What is the current status of trial NCT05649826?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2023-02-01. Estimated completion is 2027-05-01.
What conditions does trial NCT05649826 study?
This clinical trial studies the following conditions: Ultrasound Imaging.
Who is sponsoring clinical trial NCT05649826?
This trial is sponsored by UltraSight, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05649826 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI